New numbing shot could ease brain surgery recovery
NCT ID NCT07344181
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a single injection of liposomal bupivacaine, a long-acting numbing drug, can provide better pain relief after brain surgery than the standard numbing drug. About 118 adults having elective brain surgery will be randomly assigned to receive either the new drug or the standard one. Researchers will measure pain levels, opioid use, and patient satisfaction for up to 72 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- liposomal bupivacaine
- What this could lead to
- If it works, this could provide longer-lasting pain relief after brain surgery, reducing the need for opioids and improving recovery.
- What could go wrong
- This is a small, early-stage trial (118 people) comparing two numbing drugs, so results may not apply to all patients. The new drug may not work better or could have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE CARE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100071, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple Sit-Up after surgery shorten ICU stays?
- Can we rethink surgery care for seniors?
- Can a simple phone call speed up tooth extraction recovery?
- Can a simple spray soothe Post-Surgery throat pain?
- AI watches hospital Patients' vital signs to catch decline early
- Brain training boosts shoulder rehab? new trial investigates